Mineralys Therapeutics, Inc. (MLYS)

NASDAQ: MLYS · IEX Real-Time Price · USD

13.20

-0.42 (-3.08%)

At close: Jul 19, 2024, 4:30 PM

13.28

+0.08 (0.61%)

Pre-market: Jul 20, 2024, 9:29 AM EDT

Mineralys Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-90.8	-71.9	-29.8	-19.41	-3.43
Depreciation & Amortization	0.01	0	0	0	0
Share-Based Compensation	6.5	5.06	0.46	0.08	0
Other Operating Activities	-3.25	-14.34	0.12	4.77	0.96
Operating Cash Flow	-87.54	-81.17	-29.22	-14.56	-2.46
Capital Expenditures	-0.06	0	0	0	0
Change in Investments	-76.11	-160.47	-21.76	0	0
Investing Cash Flow	-76.17	-160.47	-21.76	0	0
Share Issuance / Repurchase	115.95	203.25	-1.63	0	0
Debt Issued / Paid	0	0	0	0	3.85
Other Financing Activities	-0.06	-	129.65	23.81	-0.02
Financing Cash Flow	115.88	203.25	128.02	23.81	3.83
Net Cash Flow	-47.83	-38.4	77.04	9.25	1.37
Free Cash Flow	-87.6	-81.17	-29.22	-14.56	-2.46
Free Cash Flow Per Share	-1.95	-2.24	-5.66	-2.92	-0.05

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).